Recently, elevated NOS2 and COX2 expression was discovered in distinct immune and tumor cells upon treatment with IFNγ and cytokines or TLR4 agonists, consistent with feedforward NOS2/COX2 signaling as previously reported [10, 13]. The gene discussed is PTGS2; the disease is neoplasm.